Platform Versatility Fluxergy is building a multi-modal detection platform that handles molecular testing, chemistry, immunochemistry, and cytometry with automated, sample-to-answer workflows. This presents a sales opportunity to position the platform as a single, scalable solution for laboratories seeking to consolidate testing modalities and reduce instrument footprint.

Point-of-Care Potential The goal of bringing central-lab capabilities to the palm of the hand suggests strong demand from clinics, veterinary practices, and small-to-mid size labs seeking rapid on-site results. Engage in pilots or partnerships that demonstrate faster turnaround, lower total cost of ownership, and enhanced decision-making at the point of care.

Regulatory & Partnerships Recent collaborations with NIH NIAID and CE-IVD marking for COVID-19 RT-PCR highlight a path for joint development, validation, and reimbursement strategies. Target research institutions and distributors with co-development opportunities and validated use-cases to accelerate adoption.

Global Adoption Deployment across US, Canada, and EU veterinary labs indicates international scalability and ongoing support needs. Propose regional deployment programs, training packages, and service tiers to capture multi-market opportunities and expand reference sites.

Financial Fit With a mid-market revenue profile and a relatively lean team, Fluxergy may favor bundled, outcome-based pricing, financing options, and ROI-focused proposals that emphasize reduced lab overhead, faster time-to-result, and scalable test menus aligned with customer growth.